Mercer Global Advisors’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$246K Buy
3,296
+142
+5% +$10.2K ﹤0.01% 3036
2026
Q1
$225K Buy
+3,154
New +$216K ﹤0.01% 2719
2023
Q2
Sell
-3,117
Closed -$223K 2001
2023
Q1
$223K Sell
3,117
-42
-1% -$3.33K ﹤0.01% 1672
2022
Q4
$223K Buy
+3,159
New +$223K ﹤0.01% 1654
2021
Q3
Sell
-9,835
Closed -$800K 1796
2021
Q2
$800K Buy
9,835
+1,777
+22% +$143K 0.01% 937
2021
Q1
$609K Buy
+8,058
New +$587K 0.01% 994
2020
Q3
Sell
-3,826
Closed -$201K 1271
2020
Q2
$201K Buy
+3,826
New +$182K ﹤0.01% 1008

Other funds holding NGVT

Mercer Global Advisors's NGVT Position: Q2 2026 in Review

Mercer Global Advisors increased its Ingevity (NGVT) stake by 4.5% in Q2 2026, buying an estimated $10.2K and bringing the position to 3,296 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #3036.

Mercer Global Advisors first reported a position in NGVT in Q2 2020 and has held it in 7 quarters since. The position peaked at $800K in Q2 2021. 315 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • Mercer Global Advisors held 3,296 shares of Ingevity worth $246K as of Q2 2026.
  • Mercer Global Advisors bought 142 Ingevity shares in Q2 2026, an estimated $10.2K.
  • Ingevity made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3036 holding.
  • Mercer Global Advisors first reported a position in Ingevity in Q2 2020 and has held it in 7 quarters since.
  • Mercer Global Advisors's Ingevity position peaked at $800K in Q2 2021.
  • 315 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.